Company intelligence
Celegence
Global Regulatory Affairs Services & Technology for the Life Sciences Industry.
About Celegence
Celegence provides services and solutions to support the Life Sciences industry with regulatory affairs operations and strategy. We aim to help Life Sciences companies navigate complex global regulatory requirements by providing depth of experience and an extensive delivery capability. As regulatory specialists, we work across all phases of the product lifecycle from regulatory strategy, authoring, and all aspects of established product maintenance, including submission management, publishing and health authority interaction. We leverage a global team of consultants to provide local regulatory insight, strategy and intelligence. Our mission is to collaborate with our customers to deliver Regulatory Affairs efficiency that allows them to focus on what matters most: providing exceptional patient value. We support companies in ensuring regulatory compliance across the globe by providing fully trained resources who understand the regulations and can leverage this knowledge to assist our clients in their day-to-day operations. Celegence is a privately owned business headquartered in Chicago, IL with offices in the U.K., Europe, and Bangalore(India).
Verified activity
Signals from Celegence
7 published signals
Presence & Recognition
Celegence is attending RAPS Convergence 2026 in Charlotte, North Carolina, Booth 800, from September 15 to 17, 2026.
Reported by Celegence
Research & Knowledge
Celegence published a thought leadership blog exploring how to assess existing CMC content for migration readiness, moving from document migration to information migration, building traceability and content reuse into CMC operations, and where AI can accelerate migration while experts retain regulatory judgment.
Reported by Celegence
Presence & Recognition
Celegence is attending the RAPSConvergence2026 event at Booth #800.
Reported by Celegence
Research & Knowledge
Celegence published a thought leadership blog by Dr. Alpa Ben exploring common systematic literature review deficiencies and practical approaches for EU MDR.
Reported by Celegence
Research & Knowledge
Celegence published a thought leadership blog exploring when an NBOp is required under Article 117, what Notified Bodies assess, key documentation and GSPR considerations, and planning for NBOp timelines and lifecycle changes.
Reported by Celegence
Research & Knowledge
Celegence published a thought leadership blog by Rohit Nehra, SME – Regulatory Affairs, Medical Device Services, exploring when an NBOp is required under Article 117, what Notified Bodies assess, key documentation and GSPR considerations, and planning for NBOp timelines and lifecycle changes.
Reported by Cheryl Jessen
Research & Knowledge
Celegence published a thought leadership blog by Stef Schutte, SVP, Regulatory Affairs, exploring common regulatory mistakes for emerging biotech and pharma companies.
Reported by Celegence